Companies: 10,795·Total market cap: $144.5T
Dermapharm Holding SE

Dermapharm Holding SE

DMPHFOTCHealthcare● Active
$59.00
+$19.44(+49.14%)
Market Cap$2.9B
P/E Ratio
52W High$59
52W Low$39.56
Overview

Dermapharm Holding SE(DMPHF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · DMPHF · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$1.16B$1.18B$1.15B$1.02B$0.94B
Cost of Revenue$0.77B$0.41B$0.45B$0.36B$0.32B
Gross Profit$0.39B$0.77B$0.70B$0.66B$0.62B
Gross Margin %(computed)33.62%64.96%61.19%64.49%65.83%
Operating Expenses
R&D Expenses$0.01B$0.01B$0.02B$0.01B$0.01B
G&A Expenses$0.00B$0.01B$0.02B$0.02B$0.01B
Total Operating Expenses$0.17B$0.55B$0.52B$0.42B$0.33B
Operating Income$0.22B$0.22B$0.18B$0.24B$0.30B
Operating Margin %(computed)19.03%18.37%15.89%23.78%31.65%
Interest Income$0.01B$0.01B$0.00B$0.00B$0.00B
Interest Expense$0.05B$0.06B$0.05B$0.01B$0.01B
Income Before Tax$0.18B$0.17B$0.11B$0.22B$0.29B
Income Tax Expense$0.05B$0.06B$0.05B$0.08B$0.08B
Net Income$0.13B$0.11B$0.06B$0.13B$0.21B
Net Margin %(computed)11.37%9.64%5.42%13.10%22.23%
Per Share & EBITDA
EPS (Basic)$2.46$2.11$1.16$2.49$3.89
Wtd Avg Shares0.05B0.05B0.05B0.05B0.05B
EBITDA$0.31B$0.32B$0.26B$0.32B$0.36B
EBITDA Margin %(computed)26.98%27.18%22.83%31.57%37.86%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · EUR · B

深入了解Dermapharm Holding SE

关于Dermapharm Holding SE(DMPHF)损益表

Dermapharm Holding SE(DMPHF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,DMPHF实现营收$1.16B,毛利润$0.39B(毛利率33.62%),净利润$0.13B(净利率11.37%)。

常见问题

DMPHF · 4 问

Dermapharm Holding SE(DMPHF)2025财年营收为$1.16B,同比down1.4%。

DMPHF revenueDMPHF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08